Chemoinformaics analysis of (22E)-stigmasta-4,22,25-trien-3-one
| Molecular Weight | 408.67 | nRot | 5 |
| Heavy Atom Molecular Weight | 364.318 | nRig | 23 |
| Exact Molecular Weight | 408.339 | nRing | 4 |
| Solubility: LogS | -6.685 | nHRing | 0 |
| Solubility: LogP | 7.121 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 78.5709 |
| nHD | 0 | BPOL | 45.0091 |
| QED | 0.422 |
| Synth | 4.769 |
| Natural Product Likeliness | 2.929 |
| NR-PPAR-gamma | 0.336 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.366 |
| Pgp-sub | 0 |
| HIA | 0.01 |
| CACO-2 | -4.735 |
| MDCK | 0.00000705 |
| BBB | 0.932 |
| PPB | 0.985316 |
| VDSS | 2.663 |
| FU | 0.0148622 |
| CYP1A2-inh | 0.07 |
| CYP1A2-sub | 0.642 |
| CYP2c19-inh | 0.128 |
| CYP2c19-sub | 0.928 |
| CYP2c9-inh | 0.206 |
| CYP2c9-sub | 0.242 |
| CYP2d6-inh | 0.065 |
| CYP2d6-sub | 0.892 |
| CYP3a4-inh | 0.62 |
| CYP3a4-sub | 0.724 |
| CL | 14.683 |
| T12 | 0.04 |
| hERG | 0.015 |
| Ames | 0.017 |
| ROA | 0.06 |
| SkinSen | 0.033 |
| Carcinogencity | 0.129 |
| EI | 0.011 |
| Respiratory | 0.951 |
| NR-Aromatase | 0.033 |
| Antiviral | No |
| Prediction | 0.634386 |